• Something wrong with this record ?

Pituitary adenoma treatment plan quality comparison between linear accelerator volumetric modulated arc therapy and Leksell Gamma Knife® radiosurgery

T. Veselsky, T. Syruckova, A. Kindlova, P. Osmancikova

. 2021 ; 46 (4) : 440-448. [pub] 20210724

Language English Country United States

Document type Journal Article

Persistent link   https://www.medvik.cz/link/bmc22004730

The aim of this study was to compare radiosurgical treatment plan quality of a linear accelerator with Leksell Gamma Knife (LGK) for pituitary adenoma irradiation. Thirty pituitary adenoma patients were evaluated in this study. Treatment plans were prepared on LGK and stereotactic linear accelerator Varian TrueBeam STx. Volumetric Modulated Arc Therapy (VMAT) plans (21 plans with 2 coplanar arcs and 9 plans with 4 non-coplanar arcs) were calculated for linear accelerator. All the plans were evaluated in terms of conformity, selectivity, gradient index and organ at risk (OAR) sparing. VMAT produced dosimetrically comparable treatment plans to LGK regarding conformity and selectivity (New Conformity Index (NCI): 1.76 ± 0.65 for 4 arc VMAT, 2.33 ± 1,16 for 2 arc VMAT and 1.96 ± 0.71 for LGK; Selectivity Index (SI): 0.63 ± 0.16 for 4 arc VMAT, 0.51 ± 0.16 for 2 arc VMAT and 0.58 ± 0.17 for LGK). Gradient index (GI) was superior for LGK plans (GI: 2.74 ± 0.20 for LGK and 5.28 ± 2.29 for 4 arc VMAT). OAR sparing for optics, brainstem, and hypophysis was similar for both modalities while target volume coverage was maintained the same. Finally, treatment time resulted in favor of VMAT plans (in this study VMAT plans were almost 5 times faster than LGK treatment regarding beam on time). According to the results of this study stereotactic linear accelerator with VMAT treatment could be used as a reasonable alternative to LGK for pituitary adenoma radiosurgery but only if the same head fixation method accuracy and target volume delineation are maintained for both modalities.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22004730
003      
CZ-PrNML
005      
20220127145032.0
007      
ta
008      
220113s2021 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.meddos.2021.06.003 $2 doi
035    __
$a (PubMed)34312022
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Veselsky, T $u Motol University Hospital, Oncology Clinic, Prague 5, Czech Republic; Military University Hospital, Department of Radiation Therapy, Prague 6, Czech Republic; Na Homolce Hospital, Medical Physics Department, Prague 5, Czech Republic. Electronic address: veselskyt@seznam.cz
245    10
$a Pituitary adenoma treatment plan quality comparison between linear accelerator volumetric modulated arc therapy and Leksell Gamma Knife® radiosurgery / $c T. Veselsky, T. Syruckova, A. Kindlova, P. Osmancikova
520    9_
$a The aim of this study was to compare radiosurgical treatment plan quality of a linear accelerator with Leksell Gamma Knife (LGK) for pituitary adenoma irradiation. Thirty pituitary adenoma patients were evaluated in this study. Treatment plans were prepared on LGK and stereotactic linear accelerator Varian TrueBeam STx. Volumetric Modulated Arc Therapy (VMAT) plans (21 plans with 2 coplanar arcs and 9 plans with 4 non-coplanar arcs) were calculated for linear accelerator. All the plans were evaluated in terms of conformity, selectivity, gradient index and organ at risk (OAR) sparing. VMAT produced dosimetrically comparable treatment plans to LGK regarding conformity and selectivity (New Conformity Index (NCI): 1.76 ± 0.65 for 4 arc VMAT, 2.33 ± 1,16 for 2 arc VMAT and 1.96 ± 0.71 for LGK; Selectivity Index (SI): 0.63 ± 0.16 for 4 arc VMAT, 0.51 ± 0.16 for 2 arc VMAT and 0.58 ± 0.17 for LGK). Gradient index (GI) was superior for LGK plans (GI: 2.74 ± 0.20 for LGK and 5.28 ± 2.29 for 4 arc VMAT). OAR sparing for optics, brainstem, and hypophysis was similar for both modalities while target volume coverage was maintained the same. Finally, treatment time resulted in favor of VMAT plans (in this study VMAT plans were almost 5 times faster than LGK treatment regarding beam on time). According to the results of this study stereotactic linear accelerator with VMAT treatment could be used as a reasonable alternative to LGK for pituitary adenoma radiosurgery but only if the same head fixation method accuracy and target volume delineation are maintained for both modalities.
650    12
$a nádory mozku $x chirurgie $7 D001932
650    _2
$a lidé $7 D006801
650    _2
$a částice - urychlovače $7 D010315
650    12
$a nádory hypofýzy $x radioterapie $7 D010911
650    12
$a radiochirurgie $7 D016634
650    _2
$a celková dávka radioterapie $7 D011879
650    _2
$a plánování radioterapie pomocí počítače $7 D011880
650    12
$a radioterapie s modulovanou intenzitou $7 D050397
655    _2
$a časopisecké články $7 D016428
700    1_
$a Syruckova, T $u Czech Technical University in Prague, Faculty of Biomedical Engineering, Kladno, Czech Republic
700    1_
$a Kindlova, A $u Motol University Hospital, Oncology Clinic, Prague 5, Czech Republic
700    1_
$a Osmancikova, P $u Motol University Hospital, Oncology Clinic, Prague 5, Czech Republic; Czech Technical University in Prague, Faculty of Nuclear Sciences and Physical Engineering, Department of Dosimetry and Application of Ionizing Radiation, Prague 110 00, Czech Republic
773    0_
$w MED00003228 $t Medical dosimetry : official journal of the American Association of Medical Dosimetrists $x 1873-4022 $g Roč. 46, č. 4 (2021), s. 440-448
856    41
$u https://pubmed.ncbi.nlm.nih.gov/34312022 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20220113 $b ABA008
991    __
$a 20220127145029 $b ABA008
999    __
$a ok $b bmc $g 1752033 $s 1155879
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2021 $b 46 $c 4 $d 440-448 $e 20210724 $i 1873-4022 $m Medical dosimetry $n Med Dosim $x MED00003228
LZP    __
$a Pubmed-20220113

Find record

Citation metrics

Archiving options